Nehring S

No ORCID on file · 1 paper in corpus
other 2009
Clinical chemistry and laboratory medicine ·doi:10.1515/CCLM.2009.134

BACKGROUND: The aim of this study was to assess the prognostic value of cancer antigen (CA) 125 and CA 72-4 in patients with ovarian borderline tumor (BOT). METHODS: All women diagnosed and treated for BOT at our institution between 1981 a…